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Abstract
Background and objective: Little information is available on the rapid diagnostic testing for syphilis in Burkina Faso. The 
objectives of  the study were (i) to assess the sensitivity and specificity of  four on site rapid tests in comparison with Tre-
ponema pallidum haemagglutination assay (TPHA) as a gold standard and (ii) to evaluate the operational characteristics of  
those tests among health workers in a maternity unit.
Methods: Four rapid syphilis tests commercially available in Burkina Faso were evaluated using archived serum samples and 
Treponema pallidum hemagglutination assay (TPHA) as the gold standard. Blood samples were collected between Novem-
ber 2011 and June 2012 from blood donors at the Regional Blood Transfusion Center of  Ouagadougou. The sensitivity and 
specificity of  the tests were calculated. Evaluation of  operational characteristics such as clarity of  pamphlet, complexity of  
technique, duration, was conducted in a first-level healthcare center with health workers in maternity unit. 
Results: Alere DetermineTM Syphilis was the most sensitive of  the four rapid syphilis tests evaluated. It was followed by SD 
Bioline Syphilis 3.0, Cypress Diagnostics Syphilis Quick test and Accu-Tell ® Rapid Anti-TP, which was the least sensitive. 
The four tests demonstrated a good diagnostic specificity for syphilis (95–98%), and healthcare workers found them easy 
to use.
Conclusions: The study allowed confirming the good performance of  three of  four rapid syphilis tests in Burkina Faso. 
More research will be conducted to assess the feasibility of  introducing selected rapid tests for syphilis in antenatal care 
services.  
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Introduction
Syphilis in pregnant women remains a major pub-
lic health problem. The World Health Organization 
(WHO) estimates that 90% of  syphilis cases occur in 
low-income countries1. The prevalence in developing 
countries ranges from less than 1% to 10%. In a re-
cent review among studies in 1990-2011, prevalence 
estimates were 4.5% (3.9%-5.1%) in East and southern 
Africa and 3.5% (1.8%-5.2%)  in  West and Central Af-
rica 2. In Burkina Faso, prevalence in pregnant women 
is low, with notable regional variations3,4. According to 
WHO estimates, each year, maternal syphilis is respon-
sible for at least 50,000 spontaneous abortions or still-
births and 500,000 premature births of  babies infected 
with congenital syphilis or who have low birth weight 1. 
However, rates of  congenital syphilis are generally un-
derestimated5. Congenital syphilis is an avoidable dis-
ease that prenatal testing and early treatment of  infect-
ed pregnant women could eliminate6. 
African Health Sciences Vol 15 Issue 2, June 2015                       360 361
In response to this situation, the scientific and tech-
nical consulting group of  the WHO’s Department of  
Reproductive Health and Research adopted a strategy 
for the global elimination of  congenital syphilis by 2015 
1. Consequently, many countries have included syphilis 
testing as part of  a minimum package of  tests conduct-
ed during prenatal visits. 
Unfortunately syphilis diagnosis in peripheral clinics 
(CSPSs) in Burkina Faso is conducted using a syndro-
mic approach, while the majority of  syphilis cases are 
asymptomatic. In hospital laboratories (Medical Centers 
with Surgical Services (CMA), regional hospitals (CHR), 
national hospitals (CHU)), testing is conducted with a 
venereal diseases research laboratory (VDRL) test or 
with a Treponema pallidum hemagglutination assay 
(TPHA). Although these tests present certain advan-
tages in that they allow for the differentiation between 
an old or treated syphilis infection and active syphilis, 
as well as an analysis of  treatment adherence, their use 
requires qualified personnel, laboratory equipment, and 
a source of  electricity, which limits their utility to pe-
ripheral clinics (CSPSs). 
Currently, there are several available specific, rapid 
syphilis tests that are simple to use and could be im-
plemented in CSPSs. When compared to the diagnostic 
tests currently being used (VDRL and TPHA), rapid 
treponemic tests have several advantages, including the 
rapid availability of  results ( less than 30 minutes) and 
the fact that their usage does not require electricity or 
highly qualified laboratory staff7. Simultaneous point-
of-care treponemal and non-treponemal are available 
with good performance11 and are undergoing wide 
adoption for their benefits.  However, despite reports 
of  diagnostic performance provided by the manufac-
turers of  rapid syphilis tests, data on test effectiveness 
and operational characteristics in the field remain lim-
ited in West Africa and non-existent in Burkina Faso. 
Against that background, we conducted a study to eval-
uate the diagnostic laboratory performance and opera-
tional characteristics of  four rapid tests for Treponema 
pallidum available in Burkina Faso.  The objectives of  
the study were; to assess the sensitivity and specificity 
of  four on site rapid tests in comparison with Trepone-
ma pallidum haemagglutination assay (TPHA) as a gold 
standard and to evaluate the operational characteristics 




We evaluated rapid syphilis tests commercially avail-
able in Burkina Faso using archived serum samples 
and TPHA as the gold standard. Rapid syphilis tests 
were defined as Treponema pallidum tests (i) capable 
of  giving a result within 30 minutes and (ii) that could 
be used at service delivery points without any need for 
special storage or transport7. Only rapid syphilis tests 
with market authorization in Burkina Faso (currently 
valid or in the process of  renewing validity with the 
Ministry of  Health) were considered. In total, four tests 
were selected. These were 1) Accu-Tell® Rapid An-
ti-TP (Treponema pallidum / Syphilis) (Accu Biotech 
Co Ltd, China), 2) AlereTM DetermineTM Syphilis TP 
(AlereTM Médical Co Ltd, UK), 3) Syphilis Cypress 
Diagnostics (Cypress Diagnostics, Belgium), and 4) SD 
Bioline syphilis 3.0 (Standard Diagnostics INC, Korea). 
The characteristics of  the tests according to the manu-
facturers are listed in Table 1. 
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pale (17, 15 kDa) 
Specimen Serum or plasma  
Serum, plasma or 
whole blood 
Serum, plasma or 
whole blood 
Serum, plasma or 
whole blood 
Time needed 
for results 15 minutes 
15 minutes 
24 hours maximum 5–20 minutes 5–20 minutes 
Stable result 20 minutes 24 hours 20 minutes 20 minutes 
Storage 
conditions 2–30°C 2–30°C 8–30°C 2–30°C 
 
Blood samples were collected between November 2011 
and June 2012 from blood donors at the Regional Blood 
Transfusion Center (CRTS) of  Ouagadougou, Burkina 
Faso. A total of  120 serum samples were considered 
for the evaluation. There were 60 samples positive for 
syphilis (50 samples were TPHA and VDRL positive: 
active syphilis, and 10 were TPHA positive and VDRL 
negative: previous or primary case of  syphilis) and 60 
samples negative for syphilis (50 samples were TPHA 
negative and VDRL negative, and 10 were TPHA neg-
ative and VDRL positive). The comparative analysis 
was conducted in the laboratory of  the Institut de Re-
cherche en Science de la Santé (IRSS) in Ouagadougou, 
Burkina Faso.
For the evaluation of  the operational characteristics, 
the study was conducted in a primary healthcare cen-
tre (CSPS) located in Ouagadougou the capital city of  
Burkina Faso. In total sixteen healthcare profession-
als (midwives, birth attendants, and auxiliary birth at-
tendants) working in the maternity ward of  an urban 
first-level healthcare were trained in the use of  the four 
tests. Their seniority in the maternity ward was between 
6 months and 18 years, although none had previously 
used a rapid syphilis test. However, they had used HIV 
and malaria rapid tests. 
Sample collection
After obtaining the blood donor’s consent, approxi-
mately 10 mL of  blood was taken from the blood col-
lection bag, put in a dry BD Vacutainer® tube (Becton, 
Dickinson and Company; USA) without anticoagulant 
and kept at +4°C for approximately four hours while 
waiting for the results of  the syphilis test. 
For the operational characteristics study, during the rou-
tine prenatal consultations, each healthcare worker used 
each rapid syphilis test on 5 pregnant women who con-
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sented to a blood-draw by finger prick. A self-adminis-
tered questionnaire was made available to the healthcare 
workers for the data collection. The operational charac-
teristics were appreciated following: (i) the clarity of  the 
manufacturers’ pamphlets, mainly the description of  
use, in terms of  level of  comprehension, (ii) the com-
plexity of  technique, (iii) the length of  time required 
to complete the entire testing process, (iv) the time of  
apparition of  line result, and (v) the interpretation of  
result.  For each criterion, measures were defined.
The clarity of  the manufacturer’s pamphlets was appre-
ciated regarding comprehension of  the text if  it was 
very clear, moderately clear or difficult to understand.
The complexity of  technique was looked if  the tech-
nique for utilization (from blood collection to the avail-
ability of  the result) was complex (very difficult), mod-
erately complex (difficult) or very easy in comparison 
with other rapid tests they had already used such as 
HIV test. The length of  time required for a test (from 
blood collection to the availability of  the result) was 
compared to the duration of  other rapid tests they had 
used following the modalities of  long, equivalent or 
short duration. The time for apparition of  line result 
was compared to what was written in the pamphlet of  
each test. Finally the ease in interpretation of  the result, 
in terms of  visibility and readability of  line result, was 
compared to other used rapid tests following the mo-
dalities of  very easy or moderately easy to interpret.  All 
these criteria were used to appreciate if  a test has good 
operational characteristics or not.
Laboratory methods
After blood collection from blood donors, syphilis test 
was conducted by CRTS using the ARCHITECT Syph-
ilis TP automated treponemal antibody test (Abbott Di-
agnostic, USA). This is a two-step immunoassay for the 
qualitative detection of  anti-TP antibodies in human se-
rum or plasma. It uses chemiluminescent microparticle 
immunoassay (CMIA) technology with flexible dosage 
protocols called Chemiflex. The microparticles are cov-
ered with recombinant TP antigens (TpN15, TpN17, 
and TpN47). Once the syphilis status of  the blood do-
nor was determined by CRTS, we chose positive and 
negative samples for syphilis for our evaluation. At the 
end of  the collection day, the samples were centrifuged 
at 3000 rpm for 10 minutes and then submitted to com-
bine VDRL/TPHA (BIOLABO SA, France) testing in 
the serologic laboratory of  the Institut de Recherche en 
Sciences de la Santé (IRSS) to confirm the syphilis sta-
tus. After confirmation, the serum was aliquoted in two 
cryotubes of  2 mL, labeled, and stored at -20°C until 
beginning of  the next stage of  the evaluation. Hemo-
lytic samples were excluded.
The evaluation of  the rapid syphilis tests performance 
was conducted at the laboratory of  IRSS in July 2012 
using the stock of  serum samples from CRTS. The 
evaluation followed the manufacturers’ instructions 
and used good laboratory practices.  First the frozen 
serum samples were brought to ambient temperature 
before use. Then each test was used in series. To avoid 
the comparison of  results between tests during the lab-
oratory analysis, each rapid test was used on all samples 
before moving to the next test. There was a blind in-
terpretation of  test results, independent of  the results 
of  the reference test (TPHA). TPHA (BIOLABO SA, 
http://www.biolabo.fr/pdfs/noticesFR/Syphilis) was 
used as the gold standard (reference test). It is an in-
direct hemagglutination assay (IHA) for the identifica-
tion of  Treponema pallidum antibodies circulating in 
human plasma and regularly used for the diagnosis of  
syphilis in a laboratory.
Statistical data analysis
For each test, the laboratory evaluation results were 
compared to the reference test (TPHA) and catego-
rized as true positive, false positive, true negative, or 
false negative. The data were entered with Epidata and 
analyzed using SPSS version 15 and R version 2-12.1. 
The performance characteristics, such as sensitivity 
and specificity were calculated relative to the reference 
standard TPHA results obtained for each serum spec-
imen.  
Ethical issues
The research protocol received the approval of  the 
Health Research Ethics Committee (CERS), Ministry 
of  Health, Burkina Faso.  
 
Results 
Performance of  diagnostic tests 
A total of  120 samples were tested for the evaluation 
of  the performance.  The sensitivity of  the tests was 
compared to the gold standard used (TPHA). Analysis 
of  the sensitivity of  the tests showed that Alere Deter-
mineTM syphilis TP had the highest sensitivity (93%) 
among the four selected rapid tests. The sensitivity of  
Cypress syphilis and SD Bioline Syphilis 3.0 was 90%. 
Accu-Tell ® Rapid Anti-TP had a sensitivity of  78%. 
In terms of  specificity, Alere DetermineTM syphilis TP, 
Accu-Tell ® Rapid Anti-TP and SD Bioline Syphilis 3.0 
had the same result (98%), while Cypress syphilis had a 
specificity of  95%. (Table 2) 
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Table 2 Results of the diagnostic performances of rapid syphilis tests.  
 
Accu-Tell ® Rapid 
Anti-TP (Accu 




Médical Co Ltd) 
Cypress Diagnostics 
Syphilis Quick test 
(Cypress 
Diagnostics) 
SD Bioline Syphilis 
3.0 test (Standard 
Diagnostics INC) 
Sensitivity 
(95% CI) 78% (66 - 87) 93% (84-97) 90% (79-95) 90% (80-95) 
Specificity 
(95% CI) 98% (91-100) 98% (91-100) 95% (86-98) 98% (91-100) 
     
     
CI = confidence interval 
Operational characteristics of  the four tests ac-
cording to healthcare professionals 
The results of  the evaluation of  the operational charac-
teristics of  the four tests by 16 healthcare professionals 
are summarized in Table 3. The pamphlet of  the test 
was clearly comprehensible by 12 of  the 16 respondents 
for Accu-Tell ® Rapid Anti-TP, by 11 respondents for 
SD Bioline syphilis 3.0, by 9 respondents for Cypress 
Diagnostics Syphilis Quick test, and by 7 respondents 
for Alere DetermineTM syphilis TP. 
As a whole, the healthcare professionals judged the 
technique for utilization of  the tests to be very easy. 
Indeed, of  the 16 healthcare professionals who partic-
ipated in the evaluation, 15 found Cypress Diagnostics 
Syphilis Quick test and SD Bioline Syphilis 3.0 to be 
very easy to use, while 14 said the same for Accu-Tell 
® Rapid Anti-TP and Alere DetermineTM syphilis TP.
Overall, the time needed to obtain results was deter-
mined to be similar to other tests already used for HIV 
and malaria. Specifically, 10 respondents found Alere 
DetermineTM syphilis TP and Cypress Diagnostics 
Syphilis Quick test to be similar to the previously used 
tests, and approximately 50% found this for Accu-Tell 
® Rapid Anti-TP (9/16) and SD Bioline syphilis 3.0 
(8/16). 
For the majority of  respondents, the time required to 
obtain results matched the time indicated by the manu-
facturer for Accu-Tell ® Rapid Anti-TP, Cypress Diag-
nostics Syphilis Quick test and SD Bioline syphilis 3.0 
(Table 3). 
The interpretation of  results was found to be very easy 
by 14 of  16 respondents for Accu-Tell ® Rapid An-
ti-TP and SD Bioline syphilis 3.0 and by 12 of  16 re-
spondents for Alere DetermineTM syphilis TP. As for 
Cypress Diagnostics Syphilis Quick test, only 9 of  16 
found the results to be easy to interpret.
The realization of  the tests requires the use of  equip-
ment not provided in the kit. Specific and non-specific 
equipment are needed. Specific equipment, such as cap-
illary tubes with EDTA for Alere Determine™ Syphilis 
TP and pipettes for Cypress Diagnostics Syphilis Quick 
test and SD Bioline syphilis 3.0 Accu-Tell® are need-
ed. Rapid Anti-TP does not require specific equipment. 
Non-specific equipment, including alcohol swabs and 
lancets, was required for the four tests. 
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Table 3 Operational characteristics of syphilis diagnostic tests.  




















Clarity of the test pamphlet  (n=16) (n=16) (n=16) (n=16) 
            Difficult to understand                                            2 2 1 1 
             Moderately clear 2 7 6 4 
                Very clear 12 7 9 11 
    
  Complexity of technique (n=16) (n=16) (n=16) (n=16) 
Complex 1 0 0 0 
              Moderately complex 1 2 1 1 
Very easy 14 14 15 15 
Time needed for performing  (n=16) (n=16) (n=16) (n=16) 
Long 0 4 0 0 
Equivalent 9 10 10 8 
Short 7 2 6 8 
 









Time indicated in pamphlet 15 14 15 15 
Time indicated plus 5 minutes 1 2 1 1 
 









Moderately easy 2 4 7 2 
Very easy 14 12 9 14 
 
Discussion
This is the first evaluation of  the performance and the 
characteristics of  commercially available rapid diag-
nostic syphilis tests for Burkina Faso, and it allows the 
identification of  the test that is  adapted to the context 
of  the country. To our knowledge, two of  the tests, Cy-
press Diagnostics Syphilis Quick test and Accu-Tell ® 
Rapid Anti-TP, were for the first time compared to oth-
er rapid tests for syphilis in West Africa.
All the tests used an immunochromatographic detec-
tion of  anti-Treponema pallidum antibodies. These 
tests used one or more of  several similar recombinant 
Treponema pallidum antigens, although their diagnostic 
performances in our study were different. With a sen-
sitivity of  93%, Alere DetermineTM Syphilis was the 
most sensitive of  the four rapid syphilis tests. It was fol-
lowed by SD Bioline Syphilis 3.0 and Cypress Diagnos-
tics Syphilis Quick test (Se = 90%), with Accu-Tell ® 
Rapid Anti-TP being the least sensitive (Se =78%). In 
general, the four tests demonstrated a good diagnostic 
specificity for syphilis (95 – 98%). Taking into account 
the two diagnostic criteria of  sensitivity and specificity, 
our study showed that Alere DetermineTM Syphilis had 
higher diagnostic performance than the four evaluated 
tests (Se = 93%, Sp = 98%) followed by SD Bioline 
Syphilis 3.0 (Se = 90%, Sp = 98%). The good diagnos-
tic performance of  these rapid tests compared to other 
tests has been reported in the literature10–13. However, 
few data exist regarding the performances of  Cypress 
Diagnostics Syphilis Quick test and Accu-Tell ® Rapid 
Anti-TP.
The performance of  the tests was different than what 
was indicated in the manufacturers’ pamphlets. Our 
results showed lower values than those reported for 
Cypress Diagnostics Syphilis Quick test (99.3% and 
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99.5%), Alere DetermineTM syphilis TP (100% with 
serum), and SD Bioline syphilis 3.0  (99.3% and 99.5%). 
The pamphlet for Accu-Tell ® Rapid Anti-TP did not 
give any indication of  performance. This data, which is 
crucial in the choice of  diagnostic tests, is unavailable 
in the current published literature. This result calls into 
question the criteria used for obtaining market author-
ization from the Ministry of  Health to sell rapid tests 
in Burkina Faso. Additionally, this result emphasizes the 
need to evaluate available tests on the local market to 
properly inform policy decision makers.  
The performances of  Cypress Diagnostics Syphilis 
Quick test, Alere DetermineTM syphilis TP, and SD 
Bioline syphilis in this study were in accordance with 
the threshold set by the WHO7, which recommends a 
minimum sensitivity of  85% and a minimum specific-
ity of  95%. The low sensitivity of  Accu-Tell ® Rapid 
Anti-TP (78%) when compared to the WHO threshold 
shows that this test is inappropriate for syphilis testing 
in Burkina Faso. 
The sensitivities found for Alere DetermineTM syphilis 
TP and SD Bioline syphilis 3.0 are below those found 
by Herring et al.14 using stored serum samples in Gam-
bia (100%), Tanzania (96% and 94%), and South Africa 
(96% and 94%). However, their specificities are higher 
than those found by Herring et al. and Mabey et al.13 
and similar to the results obtained in China. This varia-
tion in performance could be explained not only by am-
bient storage conditions and use of  the different tests 
but also by the use of  fluorescent treponemal antibody, 
absorbed (FTA-ABS) as reference test and the type of  
specimen used. This study, whose objective was to eval-
uate rapid syphilis tests commercially available in Burki-
na Faso, used tests bought or received by intermediaries 
of  local distributors. A direct order of  rapid tests from 
the manufacturer would have permitted the traceability 
of  the tests evaluated.  
Regarding the evaluation of  operational characteristics, 
no test was found to be easier to use than any other. We 
found all four tests to have very good operational char-
acteristics. In fact, the majority of  respondents found 
that the results were very easy to interpret, and the time 
required to use the tests was similar to that of  existing 
tests for HIV and malaria. These results are corrobo-
rated by Herring et al. for Alere DetermineTM syphilis 
TP and SD Bioline syphilis 3.0. Other studies have also 
shown rapid diagnostic syphilis tests to be easy to use15 
but this criterion is not the most important in choosing 
a diagnostic test. Although perceived favorably by the 
healthcare professionals, the four test kits were missing 
equipment. This equipment, such as alcohol swabs, lan-
cets, pipettes, and capillary tubes, is necessary to use the 
tests in the field. We recommend that the distributors 
include them in the kits to ensure correct use of  the 
tests. 
Of  the four tests, three can be performed using whole 
blood. Studies have documented the performance of  
Alere DetermineTM syphilis TP in both the laboratory 
as well as in real-world situations13. Given its simplici-
ty and its good performance in our study, which is in 
agreement with data collected in previous studies by 
other research teams, Alere DetermineTM syphilis TP 
seems to be adapted to syphilis testing in Burkina Faso. 
While our study presented the laboratory performance 
of  these tests when used with serum  samples, their 
performance with whole blood will be different16. In 
addition, providing diagnostic tests to CSPSs would al-
low for the collection of  more information on the ef-
fects of  storage conditions on test performance when 
used in rural settings. Moreover, we did not evaluate 
the effects that additional infections, such as HIV or 
malaria, could have on the performance of  these tests 
in real-world situations with whole blood.
Conclusion
Rapid syphilis tests in limited-resource countries can 
help diagnose syphilis in CSPSs that, until now, have 
used a syndromic approach to STI diagnosis. Our study 
allowed us first to confirm the good performance of  
three of  four rapid syphilis tests in Burkina Faso. Ad-
ditionally, it allowed us to identify Alere DetermineTM 
Syphilis TP as the test that is adapted to Burkina Faso. 
More research on the feasibility and acceptability of  
these rapid syphilis tests in first-level healthcare centers 
should allow for the effective implementation of  the 
recommendation for systematic testing of  pregnant 
women.
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